Skip to main content
TELCON RF PHARMACEUTICAL. Inc. logo

TELCON RF PHARMACEUTICAL. Inc. — Investor Relations & Filings

Ticker · 200230 ISIN · KR7200230001 KO Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2025-03-12 AGM Information
Country KR South Korea
Listing KO 200230

About TELCON RF PHARMACEUTICAL. Inc.

http://www.telcon-rf.com

TELCON RF PHARMACEUTICAL. Inc. operates across two primary business segments: radio frequency (RF) components and pharmaceuticals. The RF division specializes in the development, manufacturing, and global sale of components for wireless communication equipment. Its main products include RF coaxial connectors, cable assemblies, coaxial couplers, and distributors. The pharmaceutical and biotechnology division is engaged in the development and sale of medicinal products.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for Telcon RF Pharmaceutical. It contains the meeting agenda, voting procedures, director activity reports, and governance information. This document is a formal proxy statement and meeting notice sent to shareholders to solicit votes for the upcoming AGM, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-03-12 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and is a regulatory filing submitted by Telcon RF Pharmaceutical. It contains detailed information regarding the upcoming shareholder meeting, including voting procedures, proxy solicitation, and financial statements (balance sheets, income statements) provided as reference materials for shareholders. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2025-03-12 Korean
교환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory announcement regarding the adjustment of the exchange price (conversion price) for exchangeable bonds (22nd series) issued by Telcon RF Pharmaceutical. It details the change in the exchange price, the number of exchangeable shares, and the reason for the adjustment (market price decline). This type of filing relates to capital structure and financing terms, which falls under the 'Capital/Financing Update' category.
2025-03-12 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from Telcon RF Pharmaceutical regarding a significant change (over 30%) in revenue or profit/loss structure. It provides a summary table of financial performance (revenue, operating profit, net income) comparing the current fiscal year to the previous one, along with the reasons for the change. This is a standard periodic financial disclosure required by regulatory authorities (such as the KRX in Korea) when financial results deviate significantly from previous periods. It is not a full annual report (10-K) or an earnings release (ER) in the traditional sense, but rather a specific regulatory disclosure of financial variance. Therefore, it is best classified as a Regulatory Filing (RNS). FY 2024
2025-03-11 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Telcon RF Pharmaceutical. It outlines the date, location, and agenda items (financial statement approval, director appointments, and remuneration limits). This type of document is a standard proxy solicitation material provided to shareholders to inform them of an upcoming meeting and request their participation/votes, which falls under the Proxy Solicitation & Information Statement category.
2025-03-11 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Telcon RF Pharmaceutical. It contains the meeting agenda, date, location, and detailed management information regarding board activities, remuneration, and business operations. This document is a standard proxy statement/notice sent to shareholders to inform them of the upcoming meeting and provide necessary background information for voting. In the context of the provided categories, this fits the 'Proxy Solicitation & Information Statement' (PSI) classification.
2025-03-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.